News

INOVIO, a biotechnology company focused on bringing to market precisely designed DNA medicines to treat and protect people from infectious diseases and cancer, announced that the U.S. FDA has notified the company it has additional questions about the company's...

Centus Biotherapeutics Ltd., a joint venture between Fujifilm Kyowa Kirin Biologics Co., Ltd. and AstraZeneca, announced that the European Commission (EC) has granted the marketing authorization for Equidacent® (Product Code: FKB238), the company's biosimilar to Avastin® (bevacizumab). The authorization follows...

Genetron and its partner CStone Pharmaceuticals have commenced a clinical trial in China, to jointly develop a companion diagnostic (CDx) test for avapritinib. Discovered by Blueprint Medicines, Avapritinib is a US Food and Drug Administration (FDA) approved kinase inhibitor, to...

Demand for single-use assembly solutions in the biopharma industry continues to increase, with the market expected to be worth $26.89 billion by 2025. To help meet that demand, High Purity New England (HPNE), a leading supplier of biopharma equipment and...

Global contract development and manufacturing organisation (CDMO), Sterling Pharma Solutions, has announced its acquisition of Alcami’s Germantown, Wisconsin facility in the US. The new facility will further bolster Sterling’s US presence and will provide additional capacity for customer API development...

BD (Becton, Dickinson and Company), a leading global medical technology company, announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor™ Plus System has been CE marked to the IVD Directive (98/79/EC). BD has announced CE Mark...

As per the Organ Procurement and Transplantation Network, 36,527 organ transplants were accomplished in the United States in 2020. Regenerative medicines plays a vital role in transplants as it refers to an interdisciplinary field and is a branch of...